Insider Transactions in Q4 2024 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2024
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,209
-3.62%
|
$48,598
$22.0 P/Share
|
|
Dec 31
2024
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,895
+7.42%
|
-
|
|
Dec 31
2024
|
Andrew Cittadine Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
721
-1.73%
|
$15,862
$22.0 P/Share
|
|
Dec 31
2024
|
Andrew Cittadine Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,790
+4.12%
|
-
|
|
Dec 09
2024
|
Tactic Gem LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
1,433,334
-100.0%
|
-
|
|
Oct 28
2024
|
Karthik Radhakrishnan Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
1,550
+50.0%
|
$24,800
$16.25 P/Share
|